search

Active clinical trials for "Urinary Bladder, Neurogenic"

Results 111-120 of 151

Reduction of Bladder Injection Pain With Belladonna Opiate Suppository

Overactive BladderUrinary Urge Incontinence3 more

The purpose of this study is to test whether using belladonna & opiate suppositories (B&Os) can improve patient discomfort during Onabotulinumtoxin A (BoNT) injection into the bladder for treatment of overactive bladder, neurogenic detrusor overactivity, or interstitial cystitis.

Completed9 enrollment criteria

Measurement of Bladder Function Change In Patients With SVMs Before and After Surgical Intervention...

Spinal Vascular Disorder NosNeurogenic Bladder Dysfunction Nos

The investigators goal is to create a better understanding of patient with SVMs reported outcomes for bladder management strategies before and after surgery.

Unknown status2 enrollment criteria

Effect of Botulinum Toxin A on Neurogenic Detrusor Overactivity in Chronic Spinal Cord Injured Patients...

Neurogenic Bladder

This study investigated the changes in urothelial dysfunction and sensory protein expression in the bladder urothelium with time after onabotulinumtoxin injection in spinal cord injured (SCI) patients. The investigators planned to enroll 30 chronic SCI patient with neurogenic detrusor overactivity and urinary incontinence were treated with a single injection of 200 U onabotulinumtoxinA at the detrusor. Video urodynamic studies and bladder mucosal biopsies were performed at baseline, 3 months, and 6 months after treatment. Bladder tissues will be investigated for urothelial barrier and inflammation proteins as well as sensory proteins by Western blotting, between SCI patients and 10 controls, as well as successful and failed treatment groups. This study will explore the therapeutic efficacy of a single injection of 200 U onabotulinumtoxinA on neurogenic detrusor overactivity and the changes of urothelial sensory proteins in SCI patients with successful and failed treatment outcome.

Completed5 enrollment criteria

Detrusor Contraction During the Ice-water-test

Urinary BladderNeurogenic1 more

In this randomized, double-blind clinical trial including patients with a neurogenic lower urinary tract dysfunction undergoing urodynamic investigation at the Spinal Cord Injury Center, Balgrist University Hospital, Zürich, we aim to investigate whether the detrusor contraction during the ice-water-test is provoked by the ice water or the rapid filling.

Completed9 enrollment criteria

Urological Deterioration in Secondary Tethered Cord Syndrome and Clue to Detect It

Neurogenic BladderTethered Spinal Cord Syndrome

Secondary tethered cord syndrome (STCS) has been diagnosed with signs of progressive deterioration in urological or neuroorthopedic systems following primary tethering surgery. However, there is no convincing urological diagnostic clue for STCS.

Completed2 enrollment criteria

Neurogenic Bladder and Quality of Life in Patients With Stroke

StrokeComplication1 more

This study investigated effects of the neurogenic bladder on the quality of life in stroke survivors. Patients were divided into two groups: the First group consisted of patients with neurogenic bladder and the Second group consisted of patients without neurogenic bladder.

Completed15 enrollment criteria

Central Nervous System Changes Following BotulinumtoxinA Injection in the Bladder

Multiple SclerosisLower Urinary Tract Symptoms4 more

The purpose of this prospective research study is to evaluate higher neural changes following intradetrusor injection of Botulinum toxin-A (BTX-A) in patients with Multiple Sclerosis (MS). Concurrent Urodynamic and Functional Magnetic Resonance (fMRI) data will be recorded pre- and post- intravesical injection of BTX-A in patients with Multiple Sclerosis (MS) and neurogenic detrusor activity (NDO). Other objectives are to evaluate the role of urinary biomarkers such as brain-derived neurotropic factor (BDNF) and nerve growth factor (NGF) associated with bladder overactivity and, to determine whether the common validated urgency questionnaires correlate with fMRI findings and urinary biomarker concentration pre- and post- BTX-A injection in patients with MS and NDO.

Completed8 enrollment criteria

Heart Rate Variability (HRV) in Patients With Neurogenic Detrusor Overactivity (NDO) Before and...

Bladder DisorderNeurogenic

Heart rate variability (HRV) is an important indicator of cardiac autonomic function and predictor of cardiac mortality and of all-cause mortality. In this study the investigators examined changes of the HRV in patients with neurogenic detrusor overactivity (NDO) undergoing botulinum neurotoxin type A intradetrusor injections (BoNT/A).

Completed13 enrollment criteria

Efficacy of Two Onabotulinum Toxin Doses

Neurogenic BladderOveractive Detrusor

The changes in bladder function after the injection of Onabotulinum toxin into the detrusor in individuals with neurogenic bladder overactivity will be investigated retrospectively. The records of all patients treated with Onabotulinum toxin injections into the detrusor since 2000 will be evaluated. The changes in the urodynamic values after the injection of 300 units of Onabotulinum toxin will be compared with the changes after the injection of 200 units. Furthermore, the differences in urinary continence, duration between injections, side effects and complications between the two groups will be investigated.

Completed4 enrollment criteria

Study of Electroencephalogram (EEG) Measurement During Different Stimulations of the Lower Urinary...

HealthyNonneurogenic Neurogenic Bladder Dysfunction1 more

The purpose of this study is to investigate afferent and cortical activities during bladder filling under different stimulations of the lower urinary tract. The participants of the study are healthy test persons and patients with overactive bladder.

Completed7 enrollment criteria
1...111213...16

Need Help? Contact our team!


We'll reach out to this number within 24 hrs